Beyond Growth Hormone: GHRH Regulates Sleep, Energy, and Aging
A comprehensive review reveals hypothalamic GHRH does far more than trigger growth hormone—it governs sleep cycles, metabolism, and energy balance.
Summary
Growth Hormone-Releasing Hormone (GHRH), a 44-amino acid hypothalamic peptide, is best known for stimulating pituitary GH secretion. This 2025 review synthesizes decades of research to reveal GHRH's broader roles: regulating non-REM and REM sleep, influencing whole-body energy homeostasis, and interacting with key metabolic signals including ghrelin, leptin, NPY, and orexins. RNA sequencing confirms GHRH expression is highly concentrated in the human hypothalamus. Its receptor is found in arcuate, ventromedial, and periventricular hypothalamic nuclei. The review highlights that GHRH's physiological reach extends well beyond the somatotroph axis, with implications for sleep medicine, obesity, and metabolic disease.
Detailed Summary
Growth Hormone-Releasing Hormone (GHRH) was paradoxically first identified in pancreatic tumors before being confirmed as a predominantly hypothalamic peptide. This 2025 review by Dieguez, López, and Casanueva synthesizes current knowledge on GHRH's molecular biology, neuroendocrine roles, and emerging pleiotropic functions, arguing that its physiological importance extends far beyond classical GH regulation.
Structurally, GHRH is a 44-amino acid peptide derived from prepro-GHRH, with the first 29 amino acids sufficient for full biological activity. It signals through a class B G protein-coupled receptor (GHRHR), activating cAMP-PKA and MAPK pathways to enhance Pit-1 transcription factor levels and GH gene expression. Recent single-cell RNA sequencing in mice revealed co-expression of Ghrh with Trh in a glutamatergic population and with Gal in a GABAergic population within the arcuate nucleus—suggesting functional heterogeneity among GHRH neurons that was previously unappreciated.
GHRH is the primary driver of pulsatile GH secretion, counterbalanced by somatostatin. Early models proposed alternating GHRH/somatostatin bursts, but emerging evidence supports somatostatin as the primary timer of GH pulse amplitude and frequency, with tonic GHRH input. The discovery of ghrelin added complexity: ghrelin receptor (GHS-R1a) is expressed on GHRH neurons, and ghrelin modulates GHRH expression and neuronal firing. Ghrelin also stimulates GH independently of GHRH and may act as a functional somatostatin antagonist, though the precise neuronal circuitry remains unresolved. An AMPK-dependent mechanism has been proposed to mediate GH responses to both GHRH and ghrelin.
Leptin's interaction with GHRH highlights the link between energy status and the GH axis. Leptin administration reverses fasting-induced suppression of GH secretion in rodents and enhances responses to GHRH and GHRP-6. However, species differences are notable: fasting suppresses GH in rodents but elevates it in humans, and leptin administration does not significantly alter GH secretion in human subjects. Children with leptin receptor mutations—but not leptin deficiency itself—show early growth delay and subnormal GH/IGF-1, underscoring the importance of intact leptin signaling.
Perhaps most intriguingly, GHRH promotes non-REM sleep through a GH-independent mechanism and REM sleep via GH. Orexin-A (OX-A) inhibits spontaneous GH secretion by stimulating NPY neurons (which drive somatostatin release) and by inhibiting GHRH neurons in the paraventricular nucleus that project to the median eminence. This positions GHRH as a potential mediator of the inhibitory effect of orexins on REM sleep. Patients with orexin deficiency (narcolepsy) display abnormal GH secretion profiles and metabolic disturbances, further linking these systems. The authors call for future single-cell and spatial transcriptomic studies combined with functional characterization to determine whether distinct GHRH neuronal subpopulations govern sleep versus metabolic versus GH-secretory functions.
Key Findings
- GHRH expression is highly restricted to the human hypothalamus, with distinct glutamatergic and GABAergic neuron subtypes identified by single-cell RNA sequencing.
- Ghrelin receptor (GHS-R1a) on GHRH neurons modulates GHRH expression and neuronal firing, with sex-specific effects on GH and IGF-1 levels.
- GHRH promotes non-REM sleep via a GH-independent pathway and REM sleep via GH, linking it directly to the sleep-wake cycle.
- Leptin reverses fasting-induced GH suppression in rodents but shows limited effect in humans, revealing important species differences in GH regulation.
- Orexin-A inhibits GHRH neurons in the paraventricular nucleus, suggesting GHRH mediates part of orexin's suppression of REM sleep.
Methodology
This is a narrative review synthesizing published experimental and clinical evidence on GHRH biology, including rodent genetic models, human pharmacological studies, RNA sequencing datasets, and neuroendocrine physiology experiments. No original data were generated; conclusions are drawn from synthesis of existing literature.
Study Limitations
As a narrative review, the paper is subject to selection bias in literature synthesis and does not include systematic search methodology or meta-analytic rigor. Many key mechanistic findings derive from rodent models with uncertain translation to humans, particularly regarding fasting, leptin, and sleep-GH interactions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.